Transplantation Proceedings
Volume 39, Issue 10 , Pages 2937-2950, December 2007

Proliferation Signal Inhibitors in Transplantation: Questions at the Cutting Edge of Everolimus Therapy

Department of Renal Medicine, Centre for Transplant and Renal Research, Millennium Institute, University of Sydney, Westmead Hospital, Westmead, Sydney, Australia.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Authors received an honorarium for attending The PSI Forum “Proliferation signal inhibitors in transplantation: questions at the cutting edge,” held in Basel in May 2006, which was fully funded by Novartis Pharma AG.

PII: S0041-1345(07)01150-5

doi:10.1016/j.transproceed.2007.09.008

Transplantation Proceedings
Volume 39, Issue 10 , Pages 2937-2950, December 2007

Article Tools

* Image Usage & Resolution